Key facts
- This page summarizes Erin Lavelle's Form 4 filing for Eliem Therapeutics, Inc. (CLYM).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 02 Nov 2022, 19:08.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of October 31, 2022 (the "2022 Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2022 Vesting Commencement Date.